Caribou Biosciences Q1 EPS $(0.46) Misses $(0.40) Estimate, Sales $2.43M Miss $2.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Caribou Biosciences reported Q1 EPS of $(0.46), missing the $(0.40) estimate, and sales of $2.43M, below the $2.90M estimate. This represents a 30.64% decrease in sales compared to last year.
May 07, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Caribou Biosciences missed Q1 EPS and sales estimates, with a significant decrease in sales compared to last year.
Missing both EPS and sales estimates, especially with a significant year-over-year decrease in sales, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100